Ethical pharmaceutical promotion and communications worldwide: codes and regulations

, , , , , &
Philosophy, Ethics, and Humanities in Medicine 9:7 (2014)
  Copy   BIBTEX

Abstract

The international pharmaceutical industry has made significant efforts towards ensuring compliant and ethical communication and interaction with physicians and patients. This article presents the current status of the worldwide governance of communication practices by pharmaceutical companies, concentrating on prescription-only medicines. It analyzes legislative, regulatory, and code-based compliance control mechanisms and highlights significant developments, including the 2006 and 2012 revisions of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice

Categories

Keywords

Reprint years

DOI

10.1186/1747-5341-9-7

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Understanding physician-pharmaceutical industry interactions.Shaili Jain - 2007 - New York: Cambridge University Press.
Exposing Nursing Students To the Marketing Methods of Pharmaceutical Companies.Murat Civaner, Ozlem Sarikaya, Sevim Ulupinar Alici & Gulcin Bozkurt - 2008 - Nursing Ethics 15 (3):396-410.
Big pharma: a story of success in a market economy. [REVIEW]Joao Calinas-Correia - 2013 - Medicine, Health Care and Philosophy 16 (2):305-309.
The Law and Ethics of the Pharmaceutical Industry.Maurice Nelson Graham Dukes - 2005 - Elsevier.
Intellectual Property and Pharmaceutical Drugs.Richard T. De George - 2005 - Business Ethics Quarterly 15 (4):549-575.
The ethics of the pharmaceutical industry and the need for a dual market system.Anna Kreiner - 1995 - Journal of Medical Humanities 16 (1):55-68.
How Pharmaceutical Industry Employees Manage Competing Commitments in the Face of Public Criticism.Wendy Lipworth, Kathleen Montgomery & Miles Little - 2013 - Journal of Bioethical Inquiry 10 (3):355-367.
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine and Ethics 40 (2):220-233.
Codes of Business Conduct.Jayraj Jadeja, Bharat R. Shah & Preshth Bhardwaj - 2005 - International Corporate Responsibility Series 2:359-374.
Pharmaceutical medicine.D. M. Burley & Theodore Barker Binns (eds.) - 1985 - Baltimore, Md., U.S.A.: E. Arnold.
Of money and trust in medical care redux.Joel Lexchin - 2012 - Mens Sana Monographs 10 (1):143.
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.
Benchmarking and Transparency: Incentives for the Pharmaceutical Industry’s Corporate Social Responsibility. [REVIEW]Matthew Lee & Jillian Kohler - 2010 - Journal of Business Ethics 95 (4):641-658.
Pharmaceutical companies and access to medicines – social integration and ethical CSR resolution of a global public choice problem.Onyeka K. Osuji & Okechukwu Timothy Umahi - 2012 - Journal of Global Ethics 8 (2-3):139-167.

Analytics

Added to PP
2014-03-30

Downloads
22 (#690,757)

6 months
5 (#629,136)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Physicians-Pharmaceutical Sales Representatives Interactions and Conflict of Interest.Avinash R. Patwardhan - 2016 - Inquiry: The Journal of Health Care Organization, Provision, and Financing 53:004695801666759.

Add more citations

References found in this work

Code of conduct: Transparency in the net: Search engines.Carsten Welp & M. Machill - 2005 - International Review of Information Ethics 3:18.
PhRMA's Code on Interactions With Healthcare Professionals.Diane Bieri - 2010 - American Journal of Bioethics 10 (10):18-18.

Add more references